28 results
8-K
EX-99.1
CKPT
Checkpoint Therapeutics Inc
10 May 24
Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
8:45am
equivalents totaled $11.2 million, compared to $4.9 million at December 31, 2023, an increase of $6.3 million.
R&D Expenses: Research and development
8-K
EX-99.1
CKPT
Checkpoint Therapeutics Inc
22 Mar 24
Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
8:52am
of the registered direct offering that closed in January 2024 for total gross proceeds of approximately $14.0 million.
R&D Expenses: Research
8-K
EX-99.1
CKPT
Checkpoint Therapeutics Inc
13 Nov 23
Checkpoint Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
5:10pm
raised approximately $11.13 million of gross proceeds from the exercise of previously issued warrants.
R&D Expenses: Research and development expenses
8-K
EX-99.1
CKPT
Checkpoint Therapeutics Inc
14 Aug 23
Checkpoint Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
4:30pm
in a registered direct offering completed in July 2023.
R&D Expenses: Research and development expenses for the second quarter of 2023 were $13.9 million
8-K
EX-99.1
CKPT
Checkpoint Therapeutics Inc
15 May 23
Checkpoint Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
4:21pm
approximately $6.1 million of gross proceeds in a registered direct offering completed in April 2023.
R&D Expenses: Research and development expenses
8-K
EX-99.1
nl0012hj
31 Mar 23
Checkpoint Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights
6:00am
8-K
EX-99.1
d0ux613v6gb3c92rqs
8 Nov 22
Checkpoint Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
5:43pm
8-K
EX-99.1
kmafblgmuit1do31y
12 Aug 22
Checkpoint Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
8:15am
8-K
EX-99.1
qi9f4x qncrl3opj
12 May 22
Checkpoint Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
4:45pm
8-K
EX-99.1
tf9szxzr6 qty
28 Mar 22
Checkpoint Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate Highlights
7:53am
8-K
EX-99.1
67ly8
4 Nov 21
Checkpoint Therapeutics Reports Third Quarter 2021 Financial Results
4:44pm
8-K
EX-99.1
ctmjc77rgd6v
5 Aug 21
Checkpoint Therapeutics Reports Second Quarter 2021 Financial Results
4:57pm
8-K
EX-99.1
wuvyn61 z3
6 May 21
Checkpoint Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate Highlights
4:31pm
8-K
EX-99.1
1h15ce hwqft54s
9 Mar 21
Checkpoint Therapeutics Reports Full-Year 2020 Financial Results and Recent Corporate Highlights
5:17pm
8-K
EX-99.1
061 mb1jsjfh
4 Nov 20
Checkpoint Therapeutics Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights
4:31pm
8-K
EX-99.1
4plum2dtbpbqzx7ip
5 Aug 20
Checkpoint Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
4:31pm
8-K
EX-99.1
li2dqtco
6 May 20
Checkpoint Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
4:46pm
8-K
EX-99.1
lhgq1pn7zpx9rtfy7ewb
11 Mar 20
Checkpoint Therapeutics Reports Full-Year 2019 Financial Results and Recent Corporate Highlights
4:26pm
8-K
EX-99.1
vnjiesreeeka8
7 Nov 19
Checkpoint Therapeutics Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights
4:45pm
8-K
EX-99.1
bits1742br i246
8 Aug 19
Checkpoint Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
4:35pm